Literature DB >> 12162451

Nitroxides as antioxidants: Tempol protects against EO9 cytotoxicity.

Ayelet M Samuni1, William DeGraff, Murali C Krishna, James B Mitchell.   

Abstract

Nitroxide free radicals have been shown to be potent antioxidants in a variety of experimental models using diverse means of insults. Among other insults, nitroxides have been shown effective in inhibiting cytotoxicity of quinone-based drugs such as streptonigrin and mitomycin C. These drugs and other chemotherapeutic agents have the potential to undergo bioreductive activation by the normal reducing enzymes within a cell. In the present work we studied the effect of the nitroxide Tempol on the cytotoxicity induced by EO9, a mitomycin C analogue, in HT29 cells under aerobic and hypoxic conditions. The study was aimed to better understand the mechanism of EO9 cytotoxicity and the molecular level of the nitroxide's mode of protection. The reactions of Tempol with activated EO9, and the reactive species formed during EO9 activation were studied in a cell-free solution, using spin-trapping, and electron paramagnetic resonance (EPR) spectrometry. Our results indicate that EO9 induced similar cytotoxicity in HT29 cells under aerobic and hypoxic conditions while Tempol provided similar and almost complete protection to both aerobic and hypoxic cells. The results indicate that EO9 cytotoxicity is due to both 1- and 2-electron reductive activation processes, with aerobic toxicity caused by back-oxidation of the hydroquinone to the semiquinone, EO9.-. Tempol serves both as a useful tool in the study of the mechanisms of quinone-mediated cytotoxicity and as a potent antioxidant against the damaging effects of redox cycling quinones and semiquinones by scavenging of EO9.- or detoxification of O2.- and H2O2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162451

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

1.  Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species.

Authors:  S M Bailey; A D Lewis; L H Patterson; G R Fisher; R J Knox; P Workman
Journal:  Biochem Pharmacol       Date:  2001-08-15       Impact factor: 5.858

2.  Cardiac reperfusion damage prevented by a nitroxide free radical.

Authors:  D Gelvan; P Saltman; S R Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  The autoxidation of the reduced forms of EO9.

Authors:  J Butler; V J Spanswick; J Cummings
Journal:  Free Radic Res       Date:  1996-08

4.  Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9.

Authors:  J H Schellens; P Dombernowsky; J Cassidy; R Epelbaum; L Dirix; E H Cox; J Wanders; F Calabresi; R Paridaens; S Monfardini; J Wolff; W J Loos; J Verweij; N Pavlidis; A R Hanauske
Journal:  Anticancer Drugs       Date:  2001-08       Impact factor: 2.248

5.  A novel metal-free low molecular weight superoxide dismutase mimic.

Authors:  A Samuni; C M Krishna; P Riesz; E Finkelstein; A Russo
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

6.  Effects of nitroxide stable radicals on juglone cytotoxicity.

Authors:  R Zhang; O Hirsch; M Mohsen; A Samuni
Journal:  Arch Biochem Biophys       Date:  1994-08-01       Impact factor: 4.013

7.  Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines.

Authors:  J A Plumb; M Gerritsen; R Milroy; P Thomson; P Workman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-05-15       Impact factor: 7.038

8.  Nitroxide-stimulated H2O2 decomposition by peroxidases and pseudoperoxidases.

Authors:  R J Mehlhorn; C E Swanson
Journal:  Free Radic Res Commun       Date:  1992

9.  The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions.

Authors:  M P Saunders; M Jaffar; A V Patterson; J Nolan; M A Naylor; R M Phillips; A L Harris; I J Stratford
Journal:  Biochem Pharmacol       Date:  2000-04-15       Impact factor: 5.858

10.  Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase.

Authors:  M Maliepaard; A Wolfs; S E Groot; N J de Mol; L H Janssen
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

View more
  7 in total

1.  Brain redox imaging.

Authors:  Ken-ichiro Matsumoto; Fuminori Hyodo; Kazunori Anzai; Hideo Utsumi; James B Mitchell; Murali C Krishna
Journal:  Methods Mol Biol       Date:  2011

2.  Distinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity.

Authors:  Yun Wang; Joshua P Gray; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Mol Cancer Ther       Date:  2010-05-25       Impact factor: 6.261

3.  NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease.

Authors:  Jennifer J DuPont; Meghan G Ramick; William B Farquhar; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-23

4.  Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants.

Authors:  Ayelet M Samuni; Eric Y Chuang; Murali C Krishna; William Stein; William DeGraff; Angelo Russo; James B Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

Review 5.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

Review 6.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

Review 7.  Nitroxides as Antioxidants and Anticancer Drugs.

Authors:  Marcin Lewandowski; Krzysztof Gwozdzinski
Journal:  Int J Mol Sci       Date:  2017-11-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.